polatuzumab vedotin

Ligand id: 8404

Name: polatuzumab vedotin

Compound class Antibody
Approved drug? Yes (FDA (2019))
International Nonproprietary Names
INN number INN
9714 polatuzumab vedotin
ACD79B-VCMMAE | polatuzumab vedotin-piiq | Polivy® | RG-7596 | RG7596 | RO5541077-000
Polatuzumab vedotin is an antibody drug conjugate containing an anti-CD79b monoclonal antibody linked to the toxin monomethyl auristatin E (MMAE, aka vedotin; PubChem CID 11542188).
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record. Peptide sequence matches identify US8088378 as the claiming patent [1].
Database Links
GtoPdb PubChem SID 252166614
Search PubMed clinical trials polatuzumab vedotin
Search PubMed titles polatuzumab vedotin
Search PubMed titles/abstracts polatuzumab vedotin
Wikipedia Polatuzumab_vedotin